Sign in to view content

Long-term Clinical Impact of Intravitreal anti-VEGF Therapy for Severe Non-proliferative Diabetic Retinopathy (NPDR): Analyses Through a Discrete Event Simulation Model

Jennifer I. Lim, MD, FARVO, FASRS

Video
Published 2021

Related

Real-world U.S. outcomes of anti-VEGF therapy in diabetic macular edema
Thomas A. Ciulla, MD, MBA, FASRS
Updates from the Field
2017
Dry AMD Symposium 2
Annual Meeting Talks
2020
Outcomes of the HORNBILL Study: A Phase I/IIa Trial Investigating BI 764524 in Patients With Diabetic Macular Ischemia
Quan Dong Nguyen, MD, MSc, FARVO, FASRS
Updates from the Field
2024

Category: Pharmacology

See more